Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Tae Kyoung Kwak"'
Autor:
Gao Zhang, Shari Pilon-Thomas, Dmitry I. Gabrilovich, Sergio Lavilla-Alonso, Tae Kyoung Kwak, Laxminarasimha Donthireddy, Valerie Moberg, Michael J. Schell, Min Xiao, Cigdem Atay, Vito W. Rebecca, Amod A. Sarnaik, Jeffrey S. Weber, Meenhard Herlyn, Jane L. Messina, Jiufeng Tan, Allison D Richards
Publikováno v:
Clin Cancer Res
Purpose: BRAF and MEK inhibitors (BRAFi and MEKi) are actively used for the treatment of metastatic melanoma in patients with BRAFV600E mutation in their tumors. However, the development of resistance to BRAFi and MEKi remains a difficult clinical ch
Autor:
Gyong Ha Hwang, Tae Kyoung Kwak, Marc E. Lippman, Erica R. Nahin, Bonnie B. Blomberg, Alain Diaz, Barry I. Hudson, Suzanne C. Lechner, C. Taub, Michael H. Antoni, Hannah M. Fisher
Publikováno v:
Cancer. 125:1717-1725
BACKGROUND Women with breast cancer (BCa) experience heightened distress, which is related to greater inflammation and poorer outcomes. The s100 protein family facilitates the inflammatory response by regulating myeloid cell function through the bind
Autor:
Ayse Ergonul, Joyce M. Slingerland, Katherine Drews-Elger, Gyong Ha Hwang, Dorraya El-Ashry, A. Braley, Barry I. Hudson, Tae Kyoung Kwak, Marc E. Lippman
Publikováno v:
Cancer Research. 77:P3-06
Background: The Receptor for Advanced-Glycation End-products (RAGE) is highly expressed in various cancers and its expression is correlated with poorer outcomes in breast cancer. We have previously implicated RAGE in breast cancer, but whether RAGE d
Autor:
Tae Kyoung Kwak, Marc E. Lippman, Alexandra H. Besser, Dekuang Zhao, Joyce M. Slingerland, Barry I. Hudson, Katherine Drews-Elger, Ayse Ergonul
Publikováno v:
Cancer Research. 76:P2-05
Breast cancer is most common malignant state in women, with 20% of these patients developing metastasis during the course of their disease. Further understanding is needed of the process and mechanisms of metastasis. Our lab and others have been show
Autor:
Tae Kyoung Kwak, Michael J. Schell, Allison Richards, Amod A. Sarnaik, Jane L. Messina, Shari Pilon-Thomas, Cigdem Atay, Jeffrey S. Weber, Meenhard Herlyn, Vito W. Rebecca, Valerie Moberg, Dmitry I. Gabrilovich, Gao Zhang, Sergio Lavilla-Alonso
Publikováno v:
Cancer Immunology Research. 8:B41-B41
Although treatment of combination therapy with BRAF and MEK inhibitors in patient with melanoma has shown longer duration of response and higher rate of tumor responses, recurrence of tumor from dual targeted therapy in patients with metastatic melan
Autor:
Barbara Mera, Melinda Magna, Gyong Ha Hwang, Toni M. Yeasky, Thuy-Mai Le, Tae Kyoung Kwak, Barry I. Hudson, Lucas Outcault, Masaru Takabatake, Marc E. Lippman
Publikováno v:
Cancer Research. 80:P3-01
Background: Breast cancer (BC) is treatable with early detection, but once metastasis occurs, there is no cure. Therefore, it is of upmost importance to find targetable biomarkers that are involved in modulating the multi-step metastatic process. The
Autor:
Minkyung Kang, Song Hwa Park, Sunghoon Kim, Doohyung Lee, Haeng Eun Song, Sang Yeob Kim, Nam Hoon Kwon, Hye-Jin Kim, Jean Paul Thiery, Mi-Sook Lee, Doyeun Kim, Gyu Ho Lee, Dae Gyu Kim, Tai Young Kim, Jungeun Choi, Jung Weon Lee, Tae Kyoung Kwak, Seo Hee Nam, Jihye Ryu
Publikováno v:
Oncotarget
// Seo Hee Nam 1 , Doyeun Kim 2 , Mi-Sook Lee 2 , Doohyung Lee 2 , Tae Kyoung Kwak 2 , Minkyung Kang 2,3 , Jihye Ryu 2 , Hye-Jin Kim 2 , Haeng Eun Song 2 , Jungeun Choi 1 , Gyu-Ho Lee 2 , Sang-Yeob Kim 4 , Song Hwa Park 2 , Dae Gyu Kim 2 , Nam Hoon K
Autor:
Barry I. Hudson, Bonnie B. Blomberg, C. Taub, Michael H. Antoni, Tae Kyoung Kwak, Hannah M. Fisher, Erica R. Nahin, Suzanne C. Lechner, Alain Diaz, Marc E. Lippman, Molly Ream, Gyong Ha Hwang
Publikováno v:
Psychoneuroendocrinology. 107:27
Autor:
Barry I. Hudson, Bonnie B. Blomberg, Marc E. Lippman, C. Taub, Suzanne C. Lechner, Hannah M. Fisher, Michael H. Antoni, Tae Kyoung Kwak, Charles S. Carver, Erica R. Nahin, Alain Diaz, Gyong Ha Hwang
Publikováno v:
Brain, Behavior, and Immunity. 76:e29
Inflammation and social adversity have been linked to poorer long-term outcomes in breast cancer (BCa) patients, whereas greater social and family well-being (sfwb) relates to less inflammation and longer disease-free interval in BCa. S100A8A9 is a R
The receptor for advanced glycation end products (RAGE) is a multiligand transmembrane receptor that can undergo proteolysis at the cell surface to release a soluble ectodomain. Here we observed that ectodomain shedding of RAGE is critical for its ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d0321739f8cc9e74ef8e612b0d56150
https://europepmc.org/articles/PMC4933258/
https://europepmc.org/articles/PMC4933258/